Skip to main content
. 2024 Mar 8;61(7):689–698. doi: 10.1136/jmg-2023-109728

Table 1.

The variants in PLXNB2 identified in six families and the disease features observed

Patient (sex/age range) Zygosity and variants (NM_012401.4, NP_036533.2) Phenotype
Auditory Dental Developmental/neurological Vision Other
Family 1 II:3
(M/12–18)
Homozygous c.2413A>T: p.(Ile805Phe); c.2413A>T: p.(Ile805Phe) SNHL AI, conical permanent incisors Global developmental delay, moderate intellectual disability Myopia, horizontal nystagmus (congenital cataract due to CRYBB3 variant) Ear lobe skin blind-ended tracts
Family 1 II:6
(M/19–21)
Homozygous c.2413A>T: p.(Ile805Phe); c.2413A>T: p.(Ile805Phe) SNHL; labyrinthine malformation AI, conical permanent incisors Global developmental delay, epilepsy, moderate intellectual disability Severe myopia with scattered papillae, horizontal nystagmus, macular atrophy Ear lobe skin blind-ended tracts, unilateral renal agenesis, pyloric stenosis, asthma, recurrent bronchitis, intrauterine growth retardation, finger pads, watch glass toenails, overweight
Family 2 IV:2 (M/12–18) Homozygous c.2248G>A: p.(Asp750Asn); c.2248G>A: p.(Asp750Asn) SNHL AI Intellectual disability No obvious abnormality, not examined
Family 3 II:1
(M/6–11)
Compound heterozygous c.750C>A: p.(Cys250*); c.3117G>A: p.(Thr1039=) SNHL (mild) 500–4000 Hz AI with hypoplasia Normal Developmental macular abnormality with pale fundus, attenuated blood vessels, high myopia, nystagmus, microcornea Ear lobe skin blind-ended tracts, cleft palate, hypertelorism, keratopathy
Family 4 II:1
(F/19–21)
Compound heterozygous c.2606del: p.(Phe869Serfs*45); c.3982_3986del: p.(Phe1328His*65) SNHL AI; missing upper permanent lateral incisors Normal No obvious abnormality, not examined Ear lobe skin blind-ended tracts, bilateral primary lower limb lymphoedema (onset aged 3),
nevus, cellulitis
Family 5
II:1
(F/50–59)
Homozygous c.5197-337_5310del: p.(Asp1733_Arg1779del); c.5197-337_5310del: p.(Asp1733_Arg1779del) SNHL AI Mild/moderate intellectual disability No obvious abnormality, not examined Bilateral primary lower limb lymphoedema
Family 5
II:2
(M/50–59)
Homozygous c.5197-337_5310del: p.(Asp1733_Met1770del); c.5197-337_5310del: p.(Asp1733_Met1770del) SNHL AI Intellectual disability No obvious abnormality, not examined Unilateral lymphoedema of one foot
Family 6
III:1
(M/2–5)
Homozygous c.4609G>A: p.(Gly1537Ser); c.4609G>A: p.(Gly1537Ser) Could not be assessed; no current indication of hearing loss Clinical tooth failure (cause unclear); could not be assessed further Profound intellectual disability, non-verbal, autistic features, hyperactive behaviour Strabismus, no other obvious abnormality, could not be assessed Mild generalised muscular hypotonia

Splicing prediction tools suggest that exon 35 is entirely skipped leading to p.(Asp1733_Arg1779del) instead of p.(Asp1733_Met1770del) as would be predicted from the proportion of the gene deleted. Age ranges are shown for individuals to maintain anonymity. Age of onset was from birth unless otherwise stated. Variants are based on genome build GRCh37 and PLXNB2 transcript ENST00000359337.9, NM_012401.4 and PLXNB2 protein ENSP00000352288.4, NP_036533.2.

AI, amelogenesis imperfecta; SNHL, sensorineural hearing loss.